Trial intelligence / Profile preview

Evaluation of Preservative-free Lubricating Eye Drops in Novelia® Bottle for Dry Eye

NCT05661851Phase 2Completed

Sponsor
Johnson & Johnson
Start
Feb 2023
Primary completion
Apr 2023
Countries
1
01

Overview

Phase 2, randomised, single-blind trial in dry eye syndrome (DED) (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Change in Overall Quality of Ocular Comfort at 30 days. Started Feb 2023; status: completed.

02

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT05661851.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05661851.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call